State of Alaska Department of Revenue’s Avadel Pharmaceuticals AVDL Stock Holding History

State of Alaska Department of Revenue’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-5,656	Closed	-$121K	–	2194
2025 Q4	$121K	Buy	5,656 +189	+3%	+$3.67K	﹤0.01%	1743
2025 Q3	$83K	Buy	+5,467	New	+$71.1K	﹤0.01%	1703

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

State of Alaska Department of Revenue's AVDL Position: Q1 2026 in Review

State of Alaska Department of Revenue sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 5,656 shares — an estimated $121K sold.

State of Alaska Department of Revenue first reported a position in AVDL in Q3 2025 and held it in 2 quarters. The position peaked at $121K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

State of Alaska Department of Revenue reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
State of Alaska Department of Revenue sold 5,656 Avadel Pharmaceuticals shares in Q1 2026, an estimated $121K.
State of Alaska Department of Revenue first reported a position in Avadel Pharmaceuticals in Q3 2025 and held it in 2 quarters.
State of Alaska Department of Revenue's Avadel Pharmaceuticals position peaked at $121K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on State of Alaska Department of Revenue's 13F filing for Q1 2026, filed 20 Apr 2026.